| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10863-018-9755-Y |
| P698 | PubMed publication ID | 29687367 |
| P2093 | author name string | Yin He | |
| Zhuo Lv | |||
| Chun Su | |||
| Liying Lu | |||
| Xintong Yan | |||
| P2860 | cites work | Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications | Q26764899 |
| Mitochondrial Energy Metabolism and Thyroid Cancers | Q26801685 | ||
| Targeting mitochondria metabolism for cancer therapy | Q27027219 | ||
| Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action | Q27690642 | ||
| Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms | Q33702514 | ||
| Doxorubicin, DNA torsion, and chromatin dynamics | Q34039414 | ||
| FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity | Q35832107 | ||
| Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer. | Q36328030 | ||
| Pathogenetic mechanisms in thyroid follicular-cell neoplasia | Q36430189 | ||
| Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration | Q36545282 | ||
| The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia. | Q37129502 | ||
| Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells | Q37376205 | ||
| Function of mitochondrial Stat3 in cellular respiration | Q37378567 | ||
| Thyroid cancer epidemiology and prognostic variables | Q37772326 | ||
| Molecular genetics and diagnosis of thyroid cancer | Q37924088 | ||
| Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells | Q38353138 | ||
| The novel role of pyrvinium in cancer therapy. | Q38684406 | ||
| Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2/STAT5. | Q38808854 | ||
| Anaplastic Thyroid Carcinoma: Treatment in the Age of Molecular Targeted Therapy. | Q38862005 | ||
| Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex | Q38908333 | ||
| Erk1/2 activation and modulation of STAT3 signaling in oral cancer | Q38961376 | ||
| Thyroid cancer cell lines: an overview. | Q39242802 | ||
| Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3. | Q39419264 | ||
| Atovaquone derivatives as potent cytotoxic and apoptosis inducing agents. | Q39820685 | ||
| Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite | Q41929069 | ||
| Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent | Q42094834 | ||
| Establishment of human cell lines lacking mitochondrial DNA. | Q45975304 | ||
| The role of mitochondrial dysfunction in cardiovascular disease: a brief review. | Q46241976 | ||
| Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study. | Q51559180 | ||
| Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80) | Q67487758 | ||
| P577 | publication date | 2018-04-23 | |
| P1433 | published in | Journal of Bioenergetics and Biomembranes | Q5044470 |
| P1476 | title | Atovaquone enhances doxorubicin's efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer. |
| Q91592473 | Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling |
| Q58723357 | Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer |
| Q90119326 | Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing |
Search more.